life sciences
Tag details
Welcome to the 'life sciences' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'life sciences'.
Latest blogosphere posts tagged “life sciences”
-
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News
Xconomy —
Authority: 712
Roundup , deals , VC Rebecca Zacks wrote: Several of New England’s tech and life sciences firms got juicy deals the past week and a half. —Boston’s RunMyErrand, an online clearinghouse where busy people can find helpers for odd jobs, raised $1 million in a Series A venture financing round. The ...2 hours ago -
Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money
Xconomy —
Authority: 712
Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...6 hours ago -
Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs
Xconomy —
Authority: 712
Life Sciences , Drug Development , biotechnology Ryan McBride wrote: Sanofi-Aventis (NYSE: SNY ) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an ...8 hours ago -
Vertex Turns $109M Debt Into Stock
Xconomy —
Authority: 712
Biotech , Hepatitis C , Finances Luke Timmerman wrote: Vertex Pharmaceuticals, the Cambridge, MA-based developer of treatments for hepatitis C, said today that investors who hold about $109 million worth of debt securities have converted those holdings into equity stakes. The deal doesn’t leave Vertex ...14 hours ago -
Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News
Xconomy —
Authority: 712
Roundup , deals , VC Gregory T. Huang wrote: Healthcare deals are going one way, tech deals another. That’s my read from the past week in the Northwest, where we’ve seen some of the biggest biotech deals around, even as a prominent Seattle tech venture firm (and software financings in general) head ...16 hours ago -
ISB Nabs $8M for Cancer Genome
Xconomy —
Authority: 712
Biotech , Finances , Genomics Luke Timmerman wrote: The Institute for Systems Biology, a Seattle-based nonprofit research center, said today it has secured an $8 million grant from the National Institutes of Health as part of The Cancer Genome Atlas, an effort to identify new targets for cancer drugs based ...18 hours ago -
Life Technologies Acquiring BioTrove
Xconomy —
Authority: 712
Life Sciences , acquisitions , Genetic Analysis Tools Bruce V. Bigelow wrote: Life Technologies (NASDAQ: LIFE ), the Carlsbad, CA-based provider of biotech instruments and lab supplies, says it has agreed to acquire Woburn, MA-based BioTrove, which has developed a high throughput gene expression and ...20 hours ago -
Ironwood Gets $75M Deal From Astellas to Market Bowel Drug in Asia
Xconomy —
Authority: 712
Biotech , deals , Life Sciences Luke Timmerman wrote: [ Update: 10:42 am Eastern, 11/10/09 ] Cambridge, MA-based Ironwood Pharmaceuticals, the developer of a treatment for chronic constipation and irritable bowel syndrome, has formed a partnership with Japan-based Astellas Pharma to market the drug in ...21 hours ago -
Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion
Xconomy —
Authority: 712
Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...22 hours ago -
Time for Family, Time for Science
Science Progress —
Authority: 411
When Mary Ann Mason was graduate dean at the University of California, Berkeley, a frequent question she heard from women graduate students was “when is a good time to have a baby?” For women in academic science careers, the conventional wisdom was that waiting until she had achieved tenure was the best approach. ...22 hours ago -
Hamilton Thorne Raises $2.2M
Xconomy —
Authority: 712
deals , Healthcare IT , Life Sciences Wade Roush wrote: Beverly, MA-based Hamilton Thorne , which makes laser equipment used in stem-cell research labs and fertility clinics, has raised $2.2 million in a private stock placement and debt conversion deal, according to an announcement released last week. A ...23 hours ago -
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region
Xconomy —
Authority: 712
Biotech , people , startups Luke Timmerman wrote: Who are the innovators who will help keep the San Diego region’s life sciences sector vibrant in the years to come? Which of the emerging ideas here will help transform the way we treat and prevent disease around the world? And how is the San Diego ...1 day ago -
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus
Xconomy —
Authority: 712
Biotech , cancer , VC Luke Timmerman wrote: BioVex , the Woburn, MA-based company aspiring to create the first FDA-approved cancer-killing virus, has raised an additional $30 million in private financing to finish off a pivotal clinical trial needed to prove the virus is good enough to reach the U.S. ...1 day ago -
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
Xconomy —
Authority: 712
Biotech , cancer , Drugs Luke Timmerman wrote: Prostate cancer has been one of the hot fields for new biotech drug development this year, and now Cambridge, MA-based Tokai Pharmaceuticals is getting into the game with a drug that it hopes will someday help men live longer and push the boundaries of ...1 day ago -
Seattle’s Kineta Rakes in Half of $13M Federal Contract to UW For Vaccine Boosters
Xconomy —
Authority: 712
Biotech , vaccines , startups Luke Timmerman wrote: Kineta, the Seattle-based developer of drugs for autoimmune diseases , has won about half of a $13 million federal contract awarded to the University of Washington to create new compounds which might be used to boost the effectiveness of vaccines ...1 day ago -
Using SAP BusinessObjects technology in Healthcare (Part 3)
SAP Developer Network SAP Weblogs —
Authority: 152
In this blog we demonstrate the use of SAP BusinessObjects Explorer for a root-cause analysis of a clinical quality issue.1 day ago -
Where Are the Software Deals? WA Firms Raised $70M in October, Mostly in Healthcare, Gaming
Xconomy —
Authority: 712
deals , VC , trends Gregory T. Huang wrote: Early-stage software and IT deals are a scarce breed these days. That’s my initial take from looking at the October funding numbers for Washington state, courtesy of ChubbyBrain , a New York-based information services company that makes tools for investors, ...1 day ago -
Former Pfizer R&D Chief Joins PureTech Ventures as Senior Partner
Xconomy —
Authority: 712
pharma , Life Sciences , VC Ryan McBride wrote: PureTech Ventures says it has swelled its ranks with another Big Pharma veteran. John LaMattina, former president of global research and development at Pfizer, has joined the Boston-based venture firm as senior partner. PureTech has also promoted previous ...1 day ago -
Helicos Takes Itself Off Block
Xconomy —
Authority: 712
Biotech , Finances , Genomics Luke Timmerman wrote: Helicos Biosciences (NASDAQ: HLCS ) said today that it has decided to call off discussions that could lead to a sale of the company, because of its “improving standalone prospects and its current market valuation.” The Cambridge, MA-based company ...1 day ago -
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding
Xconomy —
Authority: 712
Biotech , Legal , Surgical Bleeding Luke Timmerman wrote: ZymoGenetics started really playing hardball with King Pharmaceuticals in August , and now a high-and-tight fastball has come right back at the Seattle biotech company. The projectile in question is a lawsuit filed on November 2 by Bristol, ...1 day ago
